AUROPHARMA

NSE#219 by turnover

Aurobindo Pharma Limited

₹1,712.00-4.00 (-0.23%)Close, 25 Sept 2026

Key statistics

Open: ₹1,716.00
Day range: 1,699.50 – 1,727.90
52-week range: 1,066.80 – 1,740.00
From 52w high: -1.6%
Volume: 6.25L
Turnover: ₹106.9Cr
Delivery: 46.2%
Rel volume: 0.76×
RSI (14): 57.7
ATR (14): 37.72
SMA 50: 1,633.04
SMA 200: 1,404.76

Performance

1 day: -0.23%
1 week: -1.27%
1 month: +5.48%
3 months: +10.63%
6 months: +33.89%
1 year: +51.65%

Delivery percentage

Latest: 46.2%
20-day avg: 47.8%
1-year avg: 48.3%
Percentile: 71th
Range: 6.5–78.1%

Over the last 20 sessions AUROPHARMA settled 47.8% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 48.3%. The latest session ranks higher than 71% of the 1,725 sessions on record for it.

What delivery percentage measures Scan the whole market on delivery

Fundamentals

Market cap: ₹98,505 Cr
P/E (TTM): 26.55
EPS (TTM): ₹64.49
Shares outstanding: 57.54Cr
Listed: 19 Jul 2000

Classification

Macro sector: Healthcare
Sector: Healthcare
Industry: Pharmaceuticals & Biotechnology
Basic industry: Pharmaceuticals

NSE publishes no history for this taxonomy, so it is today’s classification rather than the one that held in the past.

Growthlatest filed quarter Q1 FY27

Revenue YoY: +16.30%
Profit YoY: +25.22%
Revenue QoQ: +3.35%
Profit QoQ: +12.07%
Interest cost YoY: —

Compound growth

Not enough filed history for a compound growth rate yet.

Trailing-twelve-month figures against the same measure that many years earlier, on one reporting basis throughout. Blank where the filed history is too short or either end of the window was a loss — never a number built from less.

About

ISIN: INE406A01037
Series: EQ
History from: 19 Oct 1995
Sessions: 7,570

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 25 Sept 2026.